实用肿瘤学杂志
實用腫瘤學雜誌
실용종류학잡지
JOURNAL OF PRACTICAL ONCOLOGY
2014年
3期
228-232
,共5页
李苁%乌肖林%姚国栋%邱慧磊%张静波%宋洪涛%耿敬姝
李蓯%烏肖林%姚國棟%邱慧磊%張靜波%宋洪濤%耿敬姝
리종%오초림%요국동%구혜뢰%장정파%송홍도%경경주
人附睾分泌蛋白4%液性卵巢癌%免疫组化%CA125
人附睪分泌蛋白4%液性卵巢癌%免疫組化%CA125
인부고분비단백4%액성란소암%면역조화%CA125
HE4%Serous ovarian cancer%Immunohistochemisrtry%CA125
目的:探讨人附睾分泌蛋白4( HE4)在浆液性卵巢癌组织中的表达及与临床病理因素之间的关系。方法应用免疫组化的方法检测HE4在140例浆液性卵巢癌组织中的表达情况及与临床病理因素的关系,并联合检测CA125在卵巢癌中的组织学表达情况,对比HE4与CA125的相关性。结果HE4和CA125在中低分化浆液性卵巢癌组织中的阳性表达率分别为89.76%和81.89%,在高分化者阳性率分别为46.61%和15.38%,中晚期卵巢癌者阳性率为92.44%和83.19%,早期卵巢癌者阳性率为47.62%和33.33%,有盆腔淋巴结转移者阳性率95.65%和84.35%,无盆腔淋巴结转移者40.00%和36.00%,有腹腔种植者阳性率90.00%和87.27%,无腹腔种植者70.00%和33.33%,卵巢癌合并腹水者阳性率89.76%和79.53%,无腹水者为46.15%和38.46%,另外,HE4和CA125在浆液性卵巢癌中的阳性表达率分别为86%和76%,差异均具有统计学意义( P<0.05),两者在卵巢癌的阳性表达上存在相关性(P<0.05)。 HE4和CA125的表达与卵巢癌患者是否绝经和产数无关,(P>0.05)。结论 HE4在浆液性卵巢癌组织中的表达与FIGO分期、肿瘤分化程度、淋巴结有无转移、腹腔有无种植和是否合并腹水有关。
目的:探討人附睪分泌蛋白4( HE4)在漿液性卵巢癌組織中的錶達及與臨床病理因素之間的關繫。方法應用免疫組化的方法檢測HE4在140例漿液性卵巢癌組織中的錶達情況及與臨床病理因素的關繫,併聯閤檢測CA125在卵巢癌中的組織學錶達情況,對比HE4與CA125的相關性。結果HE4和CA125在中低分化漿液性卵巢癌組織中的暘性錶達率分彆為89.76%和81.89%,在高分化者暘性率分彆為46.61%和15.38%,中晚期卵巢癌者暘性率為92.44%和83.19%,早期卵巢癌者暘性率為47.62%和33.33%,有盆腔淋巴結轉移者暘性率95.65%和84.35%,無盆腔淋巴結轉移者40.00%和36.00%,有腹腔種植者暘性率90.00%和87.27%,無腹腔種植者70.00%和33.33%,卵巢癌閤併腹水者暘性率89.76%和79.53%,無腹水者為46.15%和38.46%,另外,HE4和CA125在漿液性卵巢癌中的暘性錶達率分彆為86%和76%,差異均具有統計學意義( P<0.05),兩者在卵巢癌的暘性錶達上存在相關性(P<0.05)。 HE4和CA125的錶達與卵巢癌患者是否絕經和產數無關,(P>0.05)。結論 HE4在漿液性卵巢癌組織中的錶達與FIGO分期、腫瘤分化程度、淋巴結有無轉移、腹腔有無種植和是否閤併腹水有關。
목적:탐토인부고분비단백4( HE4)재장액성란소암조직중적표체급여림상병리인소지간적관계。방법응용면역조화적방법검측HE4재140례장액성란소암조직중적표체정황급여림상병리인소적관계,병연합검측CA125재란소암중적조직학표체정황,대비HE4여CA125적상관성。결과HE4화CA125재중저분화장액성란소암조직중적양성표체솔분별위89.76%화81.89%,재고분화자양성솔분별위46.61%화15.38%,중만기란소암자양성솔위92.44%화83.19%,조기란소암자양성솔위47.62%화33.33%,유분강림파결전이자양성솔95.65%화84.35%,무분강림파결전이자40.00%화36.00%,유복강충식자양성솔90.00%화87.27%,무복강충식자70.00%화33.33%,란소암합병복수자양성솔89.76%화79.53%,무복수자위46.15%화38.46%,령외,HE4화CA125재장액성란소암중적양성표체솔분별위86%화76%,차이균구유통계학의의( P<0.05),량자재란소암적양성표체상존재상관성(P<0.05)。 HE4화CA125적표체여란소암환자시부절경화산수무관,(P>0.05)。결론 HE4재장액성란소암조직중적표체여FIGO분기、종류분화정도、림파결유무전이、복강유무충식화시부합병복수유관。
Objective To investigate the expression level of human epididymis protein 4 ( HE4 ) in se-rous ovarian cancer tissues and its relationship with clinicopathological features .Methods The expression level of HE4 in 140 serous ovarian cancer patients and its relationship with clinicopathological features were detected by immunohistochemistry.To compare the correlation between HE4 and CA125, the histological expressionOf CA125 was also detected by IHC .Results the positive expression rate of HE 4 and CA125 in moderately and poorly differentiated serous ovarian cancer tissues were respectively 89.76%and 81.89%;the positive expression rate in well differentiated group were respectively 46.61% and 15.38%,in the advanced stages were 92.44%and 83.19%,in the early stages were 47.62%and 33.33%.the positive expression rate of lymphatic metastasis were 95.65%and 84.35%,without lymphatic metastasis were 40.00%and 36.00%,the positive expression rate of peritoneal implantation were 90.00% and 87.27%, without peritoneal implantation were 70.00% and 33.33%;the positive expression rate of ascites were 89.76% and 79.53%,without ascites were 46.15% and 38.46%.Besides,the positive expression rates of HE4 and CA125 were 86%and 76%,the differences were sta-tistically significant.Both the positive expression in ovarian cancer are correlated positively (P<0.05).The ex-pression of HE4 and CA125 has nothing with the occurrence of pausimenia and the number of parity in patients with ovarian cancer(P>0.05).Conclusion The expression of HE4 in serous ovarian cancer is related with FI-GO stages,the degree of tumor differentiation ,lymph node metastasis and ascites .